Bioprocessing

Is RSV Vaccination Becoming a Standard for All Adults?
Biotech & Bioprocessing Is RSV Vaccination Becoming a Standard for All Adults?

For decades, respiratory syncytial virus (RSV) was largely perceived as a threat to infants and the elderly. However, a seismic shift is underway, challenging this long-held view and repositioning RSV as a significant public health concern for a much broader adult population. Recent regulatory

US Exit Creates Crisis at World Health Organization
Biotech & Bioprocessing US Exit Creates Crisis at World Health Organization

The once-unbreakable bond between the United States and the World Health Organization has officially been severed, sending shockwaves through the global public health infrastructure and raising urgent questions about the future of international cooperation in an era of resurgent nationalism. This

AI Breakthrough Creates Custom Enzymes From Scratch
Tech & Innovation AI Breakthrough Creates Custom Enzymes From Scratch

The intricate molecular machinery that underpins all life has become a canvas for artificial intelligence, leading to a new era where biological catalysts can be designed from the ground up for specific human needs. A collaborative team from Graz University of Technology and the University of Graz

Can Microbes Become Our Chemical Factories?
Biotech & Bioprocessing Can Microbes Become Our Chemical Factories?

The quest for sustainable manufacturing has led scientists to an unlikely workforce: single-celled organisms meticulously reprogrammed to produce some of the world's most valuable chemicals. This burgeoning field of synthetic biology is unlocking the potential of microbes to serve as miniature,

Novartis Urges Global Policy Shift for Life Sciences
Biotech & Bioprocessing Novartis Urges Global Policy Shift for Life Sciences

In a stark pronouncement that reverberates through the global health and economic sectors, pharmaceutical leader Novartis, in a joint analysis with the Eurasia Group, has declared the current global policy framework for life sciences dangerously outdated and on a collision course with future

Could This $141M Deal Beat Colorectal Cancer?
Biotech & Bioprocessing Could This $141M Deal Beat Colorectal Cancer?

A new strategic alliance forged in the biopharmaceutical sector has ignited a significant discussion on the future of oncology, particularly for those facing the daunting reality of advanced colorectal cancer after exhausting all standard treatment avenues. For patients diagnosed with

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later